Remedium Lifecare

1.70
-0.03
(-1.73%)
ann
There are new updates from the company21 hours ago
Viewcross
right
Market Cap
152.21 Cr
EPS
3.25
PE Ratio
8.24
Dividend Yield
0.00 %
52 Week High
16.57
52 Week Low
1.21
PB Ratio
1.63
Debt to Equity
1.08
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
259.35
#1 20,275.32
15.32
#1 89,609.60
12.69
#1 1,239
15.84
64.02
52.28
7,842.00
49.82
204.30
-94.36
192
-93.36
43.31
358.95
5,737.79
208.91
1.00
-23.08
0
13.30
58.68
488.85
3,441.50
19.33
961.40
9.35
204
401.80
42.99
62.68
2,104.52
487.22
70.60
-9.60
3
-12.50
40.33
99.25
1,772.15
464.29
146.40
-48.78
-51
450.00
31.06
156.00
1,525.27
80.07
7.10
#1 8,85,900.00
-3
#1 876.92
63.34
412.70
1,472.22
51.82
78.10
6,408.33
20
-1.89
50.66
94.78
1,164.69
29.84
131.90
108.37
12
262.79
47.14
35,099.90
1,078.80
#1 8.46
80.80
15.93
124
-65.60
47.63
Growth Rate
Revenue Growth
696.94 %
Net Income Growth
505.56 %
Cash Flow Change
-461.76 %
ROE
45.54 %
ROCE
79.01 %
EBITDA Margin (Avg.)
-8.84 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
3
4
1
0
0
3
90
505
510
4,063
1,563
Expenses
2
4
1
0
0
3
89
503
502
4,008
1,585
EBITDA
1
0
0
0
0
0
1
2
8
54
-23
Operating Profit %
-8 %
-8 %
-7 %
0 %
-43 %
13 %
1 %
0 %
1 %
1 %
0 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
-0
4
8
Profit Before Tax
1
0
0
0
0
0
1
2
7
51
-30
Tax
0
0
0
0
0
0
0
0
2
18
19
Net Profit
1
0
0
0
0
0
1
1
5
33
-50
EPS in ₹
1.63
0.03
0.01
0.04
0.02
0.77
1.33
2.99
15.07
3.25
-5.10

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
6
5
3
3
4
4
39
224
1,154
1,948
Fixed Assets
1
0
0
0
0
0
0
0
0
0
Current Assets
3
4
2
2
4
4
38
224
1,154
1,948
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
4
5
3
3
4
4
38
224
1,154
1,948
Total Liabilities
6
5
3
3
4
4
39
224
1,154
1,948
Current Liabilities
3
2
0
0
0
1
24
219
1,144
1,905
Non Current Liabilities
0
0
0
0
0
0
11
0
0
0
Total Equity
3
3
3
3
3
3
4
5
10
43
Reserve & Surplus
-1
-1
-1
-1
-1
-0
0
1
7
33
Share Capital
4
4
4
4
4
4
4
4
4
10

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
0
0
-0
1
-0
-0
1
20
-20
Investing Activities
0
2
0
0
1
-0
0
-0
0
0
Operating Activities
0
-1
0
-0
-0
-0
-10
11
21
-74
Financing Activities
-0
-0
0
0
0
0
10
-11
0
54

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Jul 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
34.96 %
8.43 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
1.11 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.04 %
0.04 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
55.23 %
83.93 %
88.18 %
88.55 %
85.86 %
86.47 %
85.88 %
85.87 %
86.24 %
86.00 %
85.50 %
80.87 %
80.30 %
82.21 %
83.33 %
84.50 %
85.01 %
86.10 %
87.29 %
Others
9.81 %
7.64 %
10.71 %
10.34 %
13.03 %
12.41 %
13.01 %
13.02 %
12.65 %
12.89 %
13.39 %
18.02 %
18.54 %
16.64 %
15.56 %
14.39 %
13.87 %
12.79 %
11.60 %
No of Share Holders
445
845
840
714
659
622
604
622
705
1,730
2,065
3,988
3,859
15,587
26,464
41,565
67,404
73,637
1,10,422

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 Apr 2025 RIGHTS Rights
61:50
15 Apr 2025 1.54 1.55
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 2.80 2.60
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 4.69 4.58
06 Jul 2024 BONUS Bonus
3:1
05 Jul 2024 11.33 14.62
26 Jun 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Jun 2024 13.56 11.33
08 Jan 2024 SPLIT Split
1:5
23 Feb 2024 19.58 19.58
23 Jun 2023 SPLIT Split
5:10
01 Sept 2023 23.44 23.44
BONUS Bonus
9:5
28 Jul 2023 23.44 0.00
30 Sept 2020 CHANGE OF NAME Change Of Name
NA
30 Sept 2020 0.20 0.20

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release21 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 28, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 28, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Apr 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 26, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Remedium Lifecare Limited Held On 24Th April 2025Apr 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 22, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 21, 2025
Board Meeting Intimation for 1. To Approve The Letter Of Offer (LOF) For The Proposed Rights Issue Of 491904000 Equity Shares Of Re. 1/- Each Aggregating To 4919.04 Lakhs For Shareholders Of The Company. 2. Any Other Item With The Permission Of The ChaiApr 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 16, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Corporate Action-Fixes Record Date For Rights IssueApr 07, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On April 07 2025Apr 07, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 02, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 02, 2025
Board Meeting Intimation for 1.To Consider And Approve The No Of Shares To Be Issued On A Rights Basis Issue Price Rights Entitlement Ratio For The Proposed Right Issue. 2.To Fix Record Date To Ascertain The Eligible Shareholders For The Proposed Right IsApr 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 29, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 27, 2025
Closure of Trading WindowMar 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 03, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 15, 2025
Integrated Filing (Financial)Feb 14, 2025
Results For The Quarter And Nine Months Ended December 31 2024. Feb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday February 14 2025.Feb 14, 2025
Board Meeting Intimation for 1) Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended 31St December 2024. 2) Any Other Business With The Permission Of The Chair.Feb 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday January 25 2025Jan 25, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 24, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 24, 2025
Reconstitution Of Committees Of The BoardJan 22, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 22, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday January 22 2025. Jan 22, 2025
Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Rumour verification - Regulation 30(11)Jan 07, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 23, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Results For The Quarter And Half Year Ended September 30, 2024.Nov 14, 2024
Board Meeting Outcome for For Meeting Held On Thursday, November 14, 2024.Nov 14, 2024
Board Meeting Intimation for 1) Consideration And Approval Of The Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2024. 2) Any Other Business With The Permission Of The Chair.Nov 09, 2024
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Reconstitution Of Committees Of The BoardOct 31, 2024
Intimation Of Appointment Of DirectorsOct 31, 2024

Technical Indicators

RSI(14)
Neutral
49.75
ATR(14)
Less Volatile
0.04
STOCH(9,6)
Neutral
34.84
STOCH RSI(14)
Oversold
10.01
MACD(12,26)
Bullish
0.01
ADX(14)
Weak Trend
19.85
UO(9)
Bearish
43.90
ROC(12)
Uptrend But Slowing Down
1.76
WillR(14)
Neutral
-71.43